Longeveron LGVN Stock
1.35 USD
{{ price }}
-3.571425%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
20.15M USD
LOW - HIGH [24H]
1.27
-
1.44 USD
VOLUME [24H]
141.28K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.62 USD
Longeveron Price Chart
Longeveron LGVN Financial and Trading Overview
| Longeveron stock price | 1.35 USD |
| Previous Close | 1.82 USD |
| Open | 1.84 USD |
| Bid | 1.88 USD x 800 |
| Ask | 1.9 USD x 1300 |
| Day's Range | 1.83 - 1.93 USD |
| 52 Week Range | 1.5 - 4.58 USD |
| Volume | 13.42K USD |
| Avg. Volume | 354.78K USD |
| Market Cap | 45.13M USD |
| Beta (5Y Monthly) | 0.819 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.62 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.15 USD |
LGVN Valuation Measures
| Enterprise Value | 43.38M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.4050632 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 58.83584 |
| Price/Book (mrq) | 6.109325 |
| Enterprise Value/Revenue | 56.557 |
| Enterprise Value/EBITDA | -2.216 |
Trading Information
Longeveron Stock Price History
| Beta (5Y Monthly) | 0.819 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 4.58 USD |
| 52 Week Low | 1.5 USD |
| 50-Day Moving Average | 2.03 USD |
| 200-Day Moving Average | 2.88 USD |
LGVN Share Statistics
| Avg. Volume (3 month) | 354.78K USD |
| Avg. Daily Volume (10-Days) | 96.02K USD |
| Shares Outstanding | 8.9M |
| Float | 7.6M |
| Short Ratio | 1.15 |
| % Held by Insiders | 18.35% |
| % Held by Institutions | 8.57% |
| Shares Short | 769.53K |
| Short % of Float | 9.44% |
| Short % of Shares Outstanding | 3.25% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3440.66% |
| Gross Margin | 21.90% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -60.88% |
| Return on Equity (ttm) | -127.0010% |
Income Statement
| Revenue (ttm) | 767K USD |
| Revenue Per Share (ttm) | 0.04 USD |
| Quarterly Revenue Growth (yoy) | -43.39% |
| Gross Profit (ttm) | 497K USD |
| EBITDA | -19578000 USD |
| Net Income Avi to Common (ttm) | -20640000 USD |
| Diluted EPS (ttm) | -0.98 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.93M USD |
| Total Cash Per Share (mrq) | 0.17 USD |
| Total Debt (mrq) | 2.19M USD |
| Total Debt/Equity (mrq) | 32.95 USD |
| Current Ratio (mrq) | 1.486 |
| Book Value Per Share (mrq) | 0.311 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17313000 USD |
| Levered Free Cash Flow (ttm) | -10919500 USD |
Profile of Longeveron
| Country | United States |
| State | FL |
| City | Miami |
| Address | Life Science and Technology Park |
| ZIP | 33136 |
| Phone | 305 909 0840 |
| Website | https://longeveron.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, a candidate in Phase 2a/b trials that is used for the treatment of alzheimer's disease, hypoplastic left heart syndrome, and aging-related frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Q&A For Longeveron Stock
What is a current LGVN stock price?
Longeveron LGVN stock price today per share is 1.35 USD.
How to purchase Longeveron stock?
You can buy LGVN shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Longeveron?
The stock symbol or ticker of Longeveron is LGVN.
Which industry does the Longeveron company belong to?
The Longeveron industry is Biotechnology.
How many shares does Longeveron have in circulation?
The max supply of Longeveron shares is 14.93M.
What is Longeveron Price to Earnings Ratio (PE Ratio)?
Longeveron PE Ratio is now.
What was Longeveron earnings per share over the trailing 12 months (TTM)?
Longeveron EPS is -2.62 USD over the trailing 12 months.
Which sector does the Longeveron company belong to?
The Longeveron sector is Healthcare.
Longeveron LGVN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
| NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
- {{ link.label }} {{link}}